{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T23:10:07Z","timestamp":1742944207274,"version":"3.40.3"},"reference-count":61,"publisher":"Japan Atherosclerosis Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT"],"published-print":{"date-parts":[[2012]]},"DOI":"10.5551\/jat.9621","type":"journal-article","created":{"date-parts":[[2012,4,16]],"date-time":"2012-04-16T04:34:20Z","timestamp":1334550860000},"page":"422-434","source":"Crossref","is-referenced-by-count":9,"title":["Low-Dose Calcitriol Decreases Aortic Renin, Blood Pressure, and Atherosclerosis in Apoe-Null Mice"],"prefix":"10.5551","volume":"19","author":[{"given":"Maya","family":"Ish-Shalom","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Sack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Vechoropoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aviv","family":"Shaish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Entin-Meer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehuda","family":"Kamari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia","family":"Maysel-Auslender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gad","family":"Keren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dror","family":"Harats","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naftali","family":"Stern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Tordjman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Kristal-Boneh E, Froom P, Harari G, Ribak J: Association of calcitriol and blood pressure in normotensive men. Hypertension, 1997; 30: 1289-1294","DOI":"10.1161\/01.HYP.30.5.1289"},{"key":"2","doi-asserted-by":"crossref","unstructured":"1) Kristal-Boneh E, Froom P, Harari G, Ribak J: Association of calcitriol and blood pressure in normotensive men. Hypertension, 1997; 30: 1289-1294","DOI":"10.1161\/01.HYP.30.5.1289"},{"key":"3","doi-asserted-by":"crossref","unstructured":"2) Kendrick J, Targher G, Smits G, Chonchol M: 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis, 2009; 205: 255-260","DOI":"10.1016\/j.atherosclerosis.2008.10.033"},{"key":"4","doi-asserted-by":"crossref","unstructured":"3) Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D'Agostino RB, Wolf M, Vasan RS: Vitamin D deficiency and risk of cardiovascular disease. Circulation, 2008; 117: 503-511","DOI":"10.1161\/CIRCULATIONAHA.107.706127"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.706127"},{"key":"6","doi-asserted-by":"crossref","unstructured":"4) Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, Kinkeldei J, Boehm BO, Weihrauch G, Maerz W: Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med, 2008; 168: 1340-1349","DOI":"10.1001\/archinte.168.12.1340"},{"key":"7","doi-asserted-by":"crossref","unstructured":"5) Melamed ML, Michos ED, Post W, Astor B: 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med, 2008; 1681629-1637","DOI":"10.1001\/archinte.168.15.1629"},{"key":"8","doi-asserted-by":"crossref","unstructured":"6) Shoji T, Shinohara K, Kimoto E, Emoto M, Tahara H, Koyama H, Inaba M, Fukumoto S, Ishimura E, Miki T, Tabata T, Nishizawa Y: Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population. Nephrol Dial Transplant, 2004; 19: 179-184","DOI":"10.1093\/ndt\/gfg513"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfg513"},{"key":"10","doi-asserted-by":"crossref","unstructured":"7) Naves-Diaz M, Alvarez-Hernandez D, Passlick-Deetjen J, Guinsburg A, Marelli C, Rodriguez-Puyol D: Oral active vitamin D is associated with improved survival in hemodialysis patients. Kidney Int, 2008; 74: 1070-1078","DOI":"10.1038\/ki.2008.343"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2008.343"},{"key":"12","doi-asserted-by":"crossref","unstructured":"8) Trivedi DP, Doll R, Khaw KT: Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomized double blind controlled trial. BMJ, 2003; 326: 469","DOI":"10.1136\/bmj.326.7387.469"},{"key":"13","doi-asserted-by":"crossref","unstructured":"9) Hsia J, Heiss G, Ren H, Allison M, Dolan NC, Greenland P, Heckbert SR, Johnson KC, Manson JE, Sidney S, Trevisan M: Women's Health Initiative Investigators: Calcium\/vitaminD supplementation and cardiovascular events. Circulation, 2007; 115: 846-854","DOI":"10.1161\/CIRCULATIONAHA.106.673491"},{"key":"14","doi-asserted-by":"crossref","unstructured":"10) Wang L, Manson JE, Song Y, Sesso HD: Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med, 2010; 152: 315-323","DOI":"10.7326\/0003-4819-152-5-201003020-00010"},{"key":"15","doi-asserted-by":"crossref","unstructured":"10) Wang L, Manson JE, Song Y, Sesso HD: Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med, 2010; 152: 315-323","DOI":"10.7326\/0003-4819-152-5-201003020-00010"},{"key":"16","doi-asserted-by":"crossref","unstructured":"11) Autier P, Gandini S: Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med, 2007; 167: 1730-1737","DOI":"10.1001\/archinte.167.16.1730"},{"key":"17","doi-asserted-by":"crossref","unstructured":"12) Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O'Garra A: 1alpha, 25-dihydroxyvitamin D3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol, 2001; 167: 4974-4980","DOI":"10.4049\/jimmunol.167.9.4974"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113004"},{"key":"19","doi-asserted-by":"crossref","unstructured":"13) Rigby WF, Denome S, Fanger MW: Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA. J Clin Invest, 1987; 79: 1659-1664","DOI":"10.1172\/JCI113004"},{"key":"20","doi-asserted-by":"crossref","unstructured":"14) Cohen-Lahav M, Douvdevani A, Chaimovitz C, Shany S: The anti-inflammatory activity of 1,25-dihydroxyvitamin D3 in macrophages. J Steroid Biochem Mol Biol, 2007; 103: 558-562","DOI":"10.1016\/j.jsbmb.2006.12.093"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.804203"},{"key":"22","doi-asserted-by":"crossref","unstructured":"15) Oh J, Weng S, Felton SK, Bhandare S, Riek A, Butler B, Proctor BM, Petty M, Chen Z, Schechtman KB, Bernal-Mizrachi L, Bernal-Mizrachi C: 1,25(OH)2 vitamin D inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation, 2009; 120: 687-698","DOI":"10.1161\/CIRCULATIONAHA.109.856070"},{"key":"23","doi-asserted-by":"crossref","unstructured":"16) Wu-Wong JR, Nakane M, Ma J, Ruan X, Kroeger PE: Effects of Vitamin D analogs on gene expression profiling in human coronary artery smooth muscle cells. Atherosclerosis, 2006; 186: 20-28","DOI":"10.1016\/j.atherosclerosis.2005.06.046"},{"key":"24","doi-asserted-by":"crossref","unstructured":"17) Aihara K, Azuma H, Akaike M, Ikeda Y, Yamashita M, Sudo T, Hayashi H, Yamada Y, Endoh F, Fujimura M, Yoshida T, Yamaguchi H, Hashizume S, Kato M, Yoshimura K, Yamamoto Y, Kato S, Matsumoto T: Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice. J Biol Chem, 2004; 279: 35798-35802","DOI":"10.1074\/jbc.M404865200"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M404865200"},{"key":"26","doi-asserted-by":"crossref","unstructured":"18) Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP: 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest, 2002; 110: 229-238","DOI":"10.1172\/JCI15219"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200215219"},{"key":"28","doi-asserted-by":"crossref","unstructured":"19) Hayek T, Attias J, Coleman R, Brodsky S, Smith J, Breslow JL, Keidar S: The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice. Cardiovasc Res, 1999; 44: 579-587","DOI":"10.1016\/S0008-6363(99)00239-4"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(99)00239-4"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1172\/JCI7818"},{"key":"31","doi-asserted-by":"crossref","unstructured":"20) Daugherty A, Manning MW, Cassis LA: Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest, 2000; 105: 1605-1612","DOI":"10.1172\/JCI7818"},{"key":"32","doi-asserted-by":"crossref","unstructured":"21) Wassmann S, Czech T, Van Eickels M, Fleming I, Bohm M, Nickenig G: Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E\/angiotensin II type 1A receptor double-knockout mice. Circulation, 2004; 110: 3062-3067","DOI":"10.1161\/01.CIR.0000137970.47771.AF"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000137970.47771.AF"},{"key":"34","unstructured":"22) Tordjman KM, Sack J, Somjen D, Posner GH, Stern N: Calcitriol, and the noncalcemic potent analog QW1624-F22, lower blood pressure in the Tsukuba hypertensive mouse. Endo 2006, Boston. P3-54, Abstract"},{"key":"35","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.107.094268"},{"key":"36","doi-asserted-by":"crossref","unstructured":"23) Tordjman KM, Semenkovich CF, Coleman T, Yudovich R, Bak S, Osher E, Vechoropoulos M, Stern N: Absence of peroxisome proliferator-activated receptor-alpha abolishes hypertension and attenuates atherosclerosis in the Tsukuba hypertensive mouse. Hypertension, 2007; 50: 945-951","DOI":"10.1161\/HYPERTENSIONAHA.107.094268"},{"key":"37","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.110.215459"},{"key":"38","doi-asserted-by":"crossref","unstructured":"24) Takeda M, Yamashita T, Sasaki N, Nakajima K, Kita T, Shinohara M, Ishida T, Hirata K: Oral administration of an active form of vitamin D3 (calcitriol) decreases atherosclerosis in mice by inducing regulatory T cells and immature dendritic cells with tolerogenic functions. Arterioscler Thromb Vasc Biol, 2010; 30: 2495-2503","DOI":"10.1161\/ATVBAHA.110.215459"},{"key":"39","doi-asserted-by":"crossref","unstructured":"25) Husain K, Suarez E, Isidro A, Ferder L: Effects of paracalcitol and enalapril on atherosclerotic injury in mouse aortas. Am J Nephrol. 2010; 32: 296-304","DOI":"10.1159\/000319445"},{"key":"40","doi-asserted-by":"crossref","unstructured":"26) Yuan W, Pan W, Kong J, Zheng W, Szeto FL, Wong KE, Cohen R, Klopot A, Zhang Z, Li YC: 1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. J Biol Chem, 2007; 282: 29821-29830","DOI":"10.1074\/jbc.M705495200"},{"key":"41","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M705495200"},{"key":"42","doi-asserted-by":"crossref","unstructured":"27) Corry DB, Eslami P, Yamamoto K, Nyby MD, Makino H, Tuck ML: Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens, 2008; 26: 269-275","DOI":"10.1097\/HJH.0b013e3282f240bf"},{"key":"43","doi-asserted-by":"crossref","unstructured":"27) Corry DB, Eslami P, Yamamoto K, Nyby MD, Makino H, Tuck ML: Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens, 2008; 26: 269-275","DOI":"10.1097\/HJH.0b013e3282f240bf"},{"key":"44","doi-asserted-by":"crossref","unstructured":"28) Xiao F, Puddefoot JR, Vinson GP: The expression of renin and the formation of angiotensin II in bovine aortic endothelial cells. J Endocrinol, 2000; 164: 207-214","DOI":"10.1677\/joe.0.1640207"},{"key":"45","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1640207"},{"key":"46","doi-asserted-by":"crossref","unstructured":"29) Daugherty A, Rateri DL, Lu H, Inagami T, Cassis LA: Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor. Circulation, 2004; 110: 3849-3857","DOI":"10.1161\/01.CIR.0000150540.54220.C4"},{"key":"47","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000150540.54220.C4"},{"key":"48","doi-asserted-by":"crossref","unstructured":"30) Keidar S, Attias J, Coleman R, Wirth K, Scholkens B, Hayek T: Attenuation of atherosclerosis in apolipoprotein E-deficient mice by ramipril is dissociated from its antihypertensive effect and from potentiation of bradykinin. J Cardiovasc Pharmacol, 2000; 35: 64-72","DOI":"10.1097\/00005344-200001000-00008"},{"key":"49","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-200001000-00008"},{"key":"50","doi-asserted-by":"crossref","unstructured":"31) Lu H, Rateri DL, Feldman DL, Charnigo RJ, Fukamizu A, Ishida J, Oesterling EG, Cassis LA, Daugherty A: Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice. J Clin Invest, 2008; 118: 984-893","DOI":"10.1172\/JCI32970"},{"key":"51","doi-asserted-by":"crossref","unstructured":"31) Lu H, Rateri DL, Feldman DL, Charnigo RJ, Fukamizu A, Ishida J, Oesterling EG, Cassis LA, Daugherty A: Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice. J Clin Invest, 2008; 118: 984-893","DOI":"10.1172\/JCI32970"},{"key":"52","doi-asserted-by":"crossref","unstructured":"32) Lassegue B, Alexander RW, Nickenig G, Clark M, Murphy TJ, Griendling KK: Angiotensin II down regulates the vascular smooth muscle AT1 receptor by transcriptional and post-transcriptional mechanisms: evidence for homologous and heterologous regulation. Mol Pharmacol, 1995; 48: 601-609","DOI":"10.1016\/S0026-895X(25)10511-7"},{"key":"53","doi-asserted-by":"crossref","unstructured":"32) Lassegue B, Alexander RW, Nickenig G, Clark M, Murphy TJ, Griendling KK: Angiotensin II down regulates the vascular smooth muscle AT1 receptor by transcriptional and post-transcriptional mechanisms: evidence for homologous and heterologous regulation. Mol Pharmacol, 1995; 48: 601-609","DOI":"10.1016\/S0026-895X(25)10511-7"},{"key":"54","doi-asserted-by":"crossref","unstructured":"33) Nguyen G, Muller DK: The biology of the (pro)renin receptor. J Am Soc Nephrol, 2010; 21: 18-23","DOI":"10.1681\/ASN.2009030300"},{"key":"55","doi-asserted-by":"crossref","unstructured":"34) Zhang J, Noble NA, Border WA, Owens RT, Huang Y: Receptor-dependent prorenin activation and induction of PAI-1 expression in vascular smooth muscle cells. Am J Physiol Endocrinol Metab, 2008; 295: E810-19","DOI":"10.1152\/ajpendo.90264.2008"},{"key":"56","doi-asserted-by":"crossref","unstructured":"35) Hayek T, Kaplan M, Kerry R, Aviram M: Macrophage NADPH oxidase activation, impaired cholesterol fluxes, and increased cholesterol biosynthesis in diabetic mice: a stimulatory role for D-glucose. Atherosclerosis, 2007; 195: 277-286","DOI":"10.1016\/j.atherosclerosis.2006.12.026"},{"key":"57","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.110.204453"},{"key":"58","doi-asserted-by":"crossref","unstructured":"36) Tesanovic S, Vinh A, Gaspari TA, Casley D, Widdop RE: Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol, 2010; 30: 1606-1613","DOI":"10.1161\/ATVBAHA.110.204453"},{"key":"59","doi-asserted-by":"crossref","unstructured":"37) Wong KE, Szeto FL, Zhang W, Ye H, Kong J, Zhang Z, Sun XJ, Li YC: Involvement of the vitamin D receptor in energy metabolism: regulation of uncoupling proteins. Am J Physiol Endocrinol Metab, 2009; 296: E820-828","DOI":"10.1152\/ajpendo.90763.2008"},{"key":"60","doi-asserted-by":"crossref","unstructured":"38) Mathieu C, Waer M, Laureys J, Rutgeerts O, Bouillon R: Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3. Diabetologia, 1994; 37: 552-558","DOI":"10.1007\/BF00403372"},{"key":"61","doi-asserted-by":"crossref","unstructured":"39) Del Pino-Montes J, Benito GE, Fernandez-Salazar MP, Covenas R, Calvo JJ, Bouillon R, Quesada JM: Calcitriol improves streptozotocin-induced diabetes and recovers bone mineral density in diabetic rats. Calcif Tissue Int, 2004; 75: 526-532","DOI":"10.1007\/s00223-004-0118-9"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T22:04:29Z","timestamp":1742940269000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/19\/5\/19_9621\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.9621","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"type":"print","value":"1340-3478"},{"type":"electronic","value":"1880-3873"}],"subject":[],"published":{"date-parts":[[2012]]}}}